Procedure for Remote Inspection as a Part of Compliance Inspection on Drugs and Regenerative Medical Products

Information

Type

Notification

Regulated products

Regenerative Medical Products

Last updated

May 25, 2022

Description

PMDA/CPE Notification No. 0525001

Organization

Country / Region

Japan

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed